Last reviewed · How we verify
Resin modified glass ionomer cement — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Resin modified glass ionomer cement (Resin modified glass ionomer cement) — Nourhan M.Aly.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Resin modified glass ionomer cement TARGET | Resin modified glass ionomer cement | Nourhan M.Aly | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Resin modified glass ionomer cement CI watch — RSS
- Resin modified glass ionomer cement CI watch — Atom
- Resin modified glass ionomer cement CI watch — JSON
- Resin modified glass ionomer cement alone — RSS
Cite this brief
Drug Landscape (2026). Resin modified glass ionomer cement — Competitive Intelligence Brief. https://druglandscape.com/ci/resin-modified-glass-ionomer-cement. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab